Evidence map›Paper›PMID 18480116›Full record

SynthesisBMJ (Clinical research ed.)2008

Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials.

Blood Pressure Lowering Treatment Trialists' Collaboration, F Turnbull, B Neal, T Ninomiya, C Algert, H Arima, F Barzi, C Bulpitt, J Chalmers, R Fagard and 6 more

Abstract readComparative StudyMeta-AnalysisReview
In one paragraph

Synthesis in BMJ (Clinical research ed.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 245 papers, 22 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
245citing papers in PubMed, 22 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

245 citing papers in PubMed, 22 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Evening versus morning dosing regimen drug therapy for hypertension.The Cochrane database of systematic reviews · 2024
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Interventions for reducing sedentary behaviour in people with stroke.The Cochrane database of systematic reviews · 2021
    Pooled it
  8. Walking for hypertension.The Cochrane database of systematic reviews · 2021
    Pooled it
  9. Pooled it
  10. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019).Hypertension research : official journal of the Japanese Society of Hypertension · 2019
    Guideline
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pharmacotherapy for hypertension in adults aged 18 to 59 years.The Cochrane database of systematic reviews · 2017
    Pooled it
  15. Guideline
  16. Guideline
  17. Pooled it
  18. Pooled it
  19. Pooled it
  20. Pooled it

185 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Blood Pressure Lowering Treatment Trialists' CollaborationGeorge Institute for International Health, University of Sydney, PO Box M201, Sydney, NSW 2050, Australia. fturnbull@george.org.au
F Turnbull
B Neal
T Ninomiya
C Algert
H Arima
F Barzi
C Bulpitt
J Chalmers
R Fagard
A Gleason
S Heritier
N Li
V Perkovic
M Woodward
S MacMahon

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo quantify the relative risk reductions achieved with different regimens to lower blood pressure in younger and older adults.

designMeta-analyses and meta-regression analyses used to compare the effects on the primary outcome between two age groups (<65 v > or =65 years). Evidence for an interaction between age and the effects of treatment sought by fitting age as a continuous variable and estimating overall effects across trials.

main outcome measuresPRIMARY OUTCOME: total major cardiovascular events.

results31 trials, with 190 606 participants, were included. The meta-analyses showed no clear difference between age groups in the effects of lowering blood pressure or any difference between the effects of the drug classes on major cardiovascular events (all P> or =0.24). Neither was there any significant interaction between age and treatment when age was fitted as a continuous variable (all P>0.09). The meta-regressions also showed no difference in effects between the two age groups for the outcome of major cardiovascular events (<65 v > or =65; P=0.38).

conclusionsReduction of blood pressure produces benefits in younger (<65 years) and older (> or =65 years) adults, with no strong evidence that protection against major vascular events afforded by different drug classes varies substantially with age.

Indexed as

AdultAgedAge FactorsAntihypertensive AgentsCerebrovascular DisordersHarm ReductionHeart DiseasesHumansHypertensionMiddle AgedPrognosisRandomized Controlled Trials as TopicRisk FactorsAntihypertensive Agents

Identifiers

PMID18480116
PMCPMC2386598

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.